Table 1.
Title/topic | Methods | Results | References |
---|---|---|---|
Expression of ESR1 vs ESR2 in endometriosis lesions compared with endometrium | Fibroblasts isolated from endometrioma and endometrium, immunohistochemistry, evaluation of methylation status of ESR2 promoter | ESR2 overexpressed in lesions compared with ESR1; mechanism involving altered methylation | Xue et al. (2007) |
Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis | Endometrial tissue biopsies from 21 women with endometriosis and 16 women without, cycle stage determined. Affymetrix arrays+gene ontogeny | Phase-dependent changes in gene expression in both tissue sets. Patient samples – enrichment of genes involved in proliferation in early secretory phase dysregulation of P target genes in secretory phase | Burney et al. (2007) |
Gene expression profile for ectopic vs eutopic endometrium provides new insights into endometriosis oncogenic potential | Paired samples of endometriomas and endometrium (12 women, luteal phase). Nimgen microarrays, validation of 20 genes, pathway analysis (DAVID) | Cluster-dependent modulation of HOX genes Altered cell cycle genes (suppressed?) |
Borghese et al. (2008) |
Prostaglandin E2 via SF-1 coordinately regulates transcription of steroidogenic genes necessary for oestrogen synthesis in endometriosis | Stromal cells isolated from wall of endometriomas (17) and endometrium (16), extra-ovarian tissue from differentgroup of women (13). RT-PCR steroid enzyme mRNAs, ChIP assays | StAR, P450scc, P450c17, P450arom are higher in ectopic samples. SF1 is high and binds promoter of StAR | Yilmaz and Bulun (2019) |
Intra-tissue steroid profiling and enzyme analysis confirms differences in steroid metabolism in the endometrium and endometriosis lesions | RT-PCR analysis of enzymes in lesions vs endometrium, LC-MS/MS for direct measurement of steroid concentrations | Altered tissue steroid concentrations in endometriosis; altered expression of various steroidogenic enzymes HSD3B2 high CYP11A1 low |
Huhtinen et al. (2012) |